The first trial that tested a GLP-1 in a population with a mood disorder was published in January 2026 by Badulescu et al in Canada, to see if semaglutide (Ozempic) was a viable treatment of cognitive dysfunction in major depressive disorder (MDD), using 72 participants over the course of 16 weeks
In trials, some patients experienced more weight loss than with Semaglutide alone, making it a strong option for those needing enhanced support in their weight loss journey
MRP1/MRP2 chimeras construction A couple of unique restriction enzyme sites x and y in the ABCC1 gene of the pcDNA5/FRT-MRP1 vector were selected to surround a fragment A which includes the fragment B, corresponding to the sequence of ABCC1 to exchange by the sequence of ABCC2 (Supplementary Table 1)
If you would like to review the official Prescribing Information, including the Boxed Warning, you can review it on the Novo Nordisk website or click here
The cycle of sperm production takes about 3 months